Benzinga | Feb 1, 2021 08:01AM EST

ConnectiveRx Announces Exclusive Partnership with Veradigm to Deliver High-Impact Point-of-Care Communications

ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, announced today that it has entered into a long-term strategic partnership with Veradigm, an Allscripts (NASDAQ:MDRX) business unit, to deliver a broad portfolio of point of care prescription-related messages to patients. The three-year agreement takes effect March 1, 2021.

Based on this partnership and the establishment of a new premium EHR network, ConnectiveRx will have the sole ability to deliver electronic coupons to more than 130 million patients nationwide via Allscripts' premier EHR platforms that include Allscripts Professional, Allscripts Touchworks, Practice Fusion (from Veradigm) and the Veradigm ePrescribe network.

"As the leader in point of care communications with the most robust EHR network partnerships, ConnectiveRx is empowering brands to reach patients with critical medical information and savings offers when and where it matters most," said ConnectiveRx CEO Harry Totonis. "In 2020, over 200 million electronic prescriptions were handled through the Allscripts/Veradigm network, and this strategic partnership provides another powerful way to reach large networks of healthcare providers and their patients."

"ConnectiveRx has exceptional and long-standing experience in delivering targeted point of care messages. Veradigm is thrilled that our partnership with ConnectiveRx will help providers and their patients improve medication awareness and adherence," said Tom Langan, CEO of Veradigm.

ConnectiveRx will be announcing the addition of other partners to its new premium EHR network throughout 2021. To learn more about the company's integrated commercialization solutions, please visit www.connectiverx.com.